FDA
approval
· 2011-04-26
FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
Summary
FDA approved a supplemental application for SAVELLA (milnacipran hydrochloride) submitted by Allergan, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SAVELLA (MILNACIPRAN HYDROCHLORIDE)